Mouse mammary stem cells express prognostic markers for triple-negative breast cancer

INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous group of tumours in which chemotherapy, the current mainstay of systemic treatment, is often initially beneficial but with a high risk of relapse and metastasis. There is currently no means of predicting which TNBC will relapse. W...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Breast Cancer Res
Glavni autori: Soady, Kelly J, Kendrick, Howard, Gao, Qiong, Tutt, Andrew, Zvelebil, Marketa, Ordonez, Liliana D, Quist, Jelmar, Tan, David Wei-Min, Isacke, Clare M, Grigoriadis, Anita, Smalley, Matthew J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4381533/
https://ncbi.nlm.nih.gov/pubmed/25849541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0539-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items